OncoMatch/Clinical Trials/NCT07776301
Application of CT-Linac-Based "All-in-One" One-Stop Radiotherapy in Breast Cancer
Is NCT07776301 recruiting? Yes, currently enrolling (Sep 2026). This NA trial studies non-drug interventions for breast cancer.
This study aims to evaluate and report the clinical adverse events and dosimetric parameters in breast cancer patients undergoing an "all-in-one (AIO)" one-stop, fully automated radiotherapy workflow. By systematically tracking these clinical and physical metrics, we seek to establish a standardized clinical protocol for AIO radiotherapy in breast cancer management.
Check if I qualifyExtracted eligibility criteria
Cancer type
Breast Carcinoma
Performance status
ECOG 0–2(Ambulatory, capable of self-care)
Prior therapy
Cannot have received: radiotherapy to the ipsilateral breast, chest wall, thorax, or regional lymph nodes
Prior history of radiotherapy to the ipsilateral breast, chest wall, thorax, or regional lymph nodes
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Frequently asked questions
Is NCT07776301 currently recruiting?
Yes, this trial is currently recruiting patients.
Are there prior therapy exclusions?
Yes. Prior radiotherapy to the ipsilateral breast, chest wall, thorax, or regional lymph nodes disqualifies patients from enrollment.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages